BackINTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026 Overview
INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026

INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026 P/E Ratio

INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026 (IQMDW) has a P/E ratio of 22.53.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

22.53

P/E Ratio

22.53

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026 (IQMDW) FAQ

INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026 posts a P/E ratio of 22.53. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026's P/E ratio of 22.53 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for IQMDW's P/E ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; INTELLIGENT MEDICINE ACQUISITION EQUITY WARRANT EXP 05TH NOV 2026's other metric pages and overview cover the third.